In-hospital mortality and failure to rescue after cytoreductive nephrectomy

European Urology

Volumn 63, Issue 6, 2013, Pages 1107-1114

  Trinh, Quoc Dien ^a,b   Bianchi, Marco ^a,c   Hansen, Jens ^a,d   Tian, Zhe ^a   Abdollah, Firas ^c   Shariat, Shahrokh F ^e   Montorsi, Francesco ^c   Perrotte, Paul ^a   Karakiewicz, Pierre I ^a   Sun, Maxine ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b HENRY FORD HEALTH SYSTEM   (United States)

^c VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^d Prostate Cancer Center Hamburg Eppendorf   (Germany)

^e WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Cytoreductive nephrectomy; In hospital mortality; Metastatic renal cell carcinoma; Morbidity

Indexed keywords

ADVERSE OUTCOME; AGED; ARTICLE; CANCER PATIENT; CANCER REGISTRY; CARDIOVASCULAR INFECTION; CLINICAL ARTICLE; COMORBIDITY; CYTOREDUCTIVE SURGERY; FEMALE; GASTROINTESTINAL INFECTION; HOSPITAL BED; HOSPITALIZATION; HUMAN; KIDNEY METASTASIS; MALE; MORTALITY; NEPHRECTOMY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; RETROSPECTIVE STUDY; SURGICAL MORTALITY; UROGENITAL TRACT INFECTION;

AGED; CARCINOMA, RENAL CELL; COMORBIDITY; FEMALE; HOSPITAL BED CAPACITY; HOSPITAL MORTALITY; HUMANS; INTRAOPERATIVE COMPLICATIONS; KIDNEY NEOPLASMS; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; NEPHRECTOMY; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES;

EID: 84876463221     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2012.08.069     Document Type: Article

References (37)

1. R.J. Motzer, N. Agarwal, and C. Beard NCCN Clinical Practice Guidelines in oncology for kidney cancer J Natl Compr Canc Netw 9 2011 960 977
2. B. Ljungberg, N.C. Cowan, and D.C. Hanbury Guidelines on renal cell carcinoma: the 2010 update Eur Urol 58 2010 398 406
3. L. Zini, U. Capitanio, and P. Perrotte Population-based assessment of survival after cytoreductive nephrectomy versus no surgery in patients with metastatic renal cell carcinoma Urology 73 2009 342 346
4. T.K. Choueiri, W. Xie, and C. Kollmannsberger The impact of cytoreductive nephrectomy on survival of patients with metastatic renal cell carcinoma receiving vascular endothelial growth factor targeted therapy J Urol 185 2011 60 66
5. A.K. Kader, P. Tamboli, and T. Luongo Cytoreductive nephrectomy in the elderly patient: the M. D. Anderson Cancer Center experience J Urol 177 2007 855 860 discussion 860-1
6. F. Abdollah, M. Sun, and R. Thuret Mortality and morbidity after cytoreductive nephrectomy for metastatic renal cell carcinoma: a population-based study Ann Surg Oncol 18 2011 2988 2996
7. M. Sun, F. Abdollah, and J. Schmitges Cytoreductive nephrectomy in the elderly: a population-based cohort from the USA BJU Int 109 2012 1807 1812
8. J. Birkmeyer, and J. Dimick Understanding and reducing variation in surgical mortality Annu Rev Med 60 2009 405 415
9. J. Silber, S. Williams, and H. Krakauer Hospital and patient characteristics associated with death after surgery Med Care 30 1992 615 629
10. A. Ghaferi, J. Birkmeyer, and J. Dimick Hospital volume and failure to rescue with high-risk surgery Med Care 49 2011 1076 1081
11. A. Ghaferi, J. Birkmeyer, and J. Dimick Variation in hospital mortality associated with inpatient surgery N Engl J Med 361 2009 1368 1375
12. A. Taenzer, J. Pyke, and S. McGrath A review of current and emerging approaches to address failure-to-rescue Anesthesiology 115 2011 421 431
13. US Department of Health and Human Services. National Center for Health Statistics and the Centers for Medicare and Medicaid Services. International classification of disease, 9th revision, clinical modification. Hyattsville, MD: US National Center for Health Statistics.
14. E.B. Lamont, J.E. Herndon, and J.C. Weeks Measuring disease-free survival and cancer relapse using Medicare claims from CALGB breast cancer trial participants (companion to 9344) J Natl Cancer Inst 98 2006 1335 1338
15. M.E. Charlson, P. Pompei, and K.L. Ales A new method of classifying prognostic comorbidity in longitudinal studies: development and validation J Chronic Dis 40 1987 373 383
16. R.A. Deyo, D. Cherkin, and M. Ciol Adapting a clinical comorbidity index for use with ICD-9-CM administrative database J Clin Epidemiol 45 1992 613 619
17. J.H. Liu, D.S. Zingmond, and M.L. McGory Disparities in the utilization of high-volume hospitals for complex surgery JAMA 296 2006 1973 1980
18. US Census 2010. US Census Bureau Web site. http://www.census.gov.
19. Healthcare Cost and Utilization Project Nationwide Inpatient Sample. NIS Description of Data Elements. Agency for Healthcare Research and Quality Web site. http://www.hcup-us.ahrq.gov/db/vars/hosp-teach/nisnote.jsp.
20. F.N. Joudi, V. Allareddy, and C.J. Kane Analysis of complications following partial and total nephrectomy for renal cancer in a population based sample J Urol 177 2007 1709 1714
21. S. Weingart, L. Iezzoni, and R. Davis Use of administrative data to find substandard care: validation of the complications screening program Med Care 38 2000 796 806
22. L. Iezzoni, J. Daley, and T. Heeren Identifying complications of care using administrative data Med Care 32 1994 700 715
23. F. Harrell, K. Lee, and D. Mark Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors Stat Med 15 1996 361 387
24. B.K. Hollenbeck, Y. Wei, and J.D. Birkmeyer Volume, process of care, and operative mortality for cystectomy for bladder cancer Urology 69 2007 871 875
25. J. Finks, N. Osborne, and J. Birkmeyer Trends in hospital volume and operative mortality for high-risk surgery N Engl J Med 364 2011 2128 2137
26. A. Brunelli, F. Xiume, and M. Al Refai Risk-adjusted morbidity, mortality and failure-to-rescue models for internal provider profiling after major lung resection Interact CadioVasc Thorac Surg 5 2006 92 96
27. A. Ghaferi, J. Birkmeyer, and J. Dimick Complications, failure to rescue, and mortality with major inpatient surgery in medicare patients Ann Surg 250 2009 1029 1034
28. H. Tan, J.J. Wolf, and Z. Ye Complications and failure to rescue after laparoscopic versus open radical nephrectomy J Urol 186 2011 1254 1260
29. R.C. Flanigan, G. Mickisch, and R. Sylvester Cytoreductive nephrectomy in patients with metastatic renal cancer: a combined analysis J Urol 171 2004 1071 1076
30. R.C. Flanigan, S.E. Salmon, and B.A. Blumenstein Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer N Engl J Med 345 2001 1655 1659
31. S.H. Culp, N.M. Tannir, and E.J. Abel Can we better select patients with metastatic renal cell carcinoma for cytoreductive nephrectomy? Cancer 116 2010 3378 3388
32. J. Liu, D. Zingmond, and M. McGory Disparities in the utilization of high-volume hospitals for complex surgery JAMA 296 2006 1973 1980
33. B.K. Hollenbeck, R.L. Dunn, and D.C. Miller Volume-based referral for cancer surgery: informing the debate J Clin Oncol 25 2006 91 96
34. J.D. Birkmeyer, Y. Sun, and S.L. Wong Hospital volume and late survival after cancer surgery Ann Surg 245 2007 777 783
35. M.N. Simmons, and I.S. Gill Decreased complications of contemporary laparoscopic partial nephrectomy: use of a standardized reporting system J Urol 177 2007 2067 2073 discussion 2073
36. L. Nogueira, D. Katz, and R. Pinochet Critical evaluation of perioperative complications in laparoscopic partial nephrectomy Urology 75 2010 288 294
37. A. Shabsigh, R. Korets, and K.C. Vora Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology Eur Urol 55 2009 164 176